Abstract
Introduction: The diabetes mellitus is a metabolic disorder and forthcoming epidemic all over the globe that is caused due to insulin resistance. In this background the adipokine-leptin could be potential and beneficial alternative treatment modality. Leptin promotes weight loss, regulation of appetite & can reverse diabetes by improving glucose tolerance by its action on hypothalamus.
Objectives: Present study will be conducted to evaluate the role of leptin in obesity associated maturity onset diabetes. Other biochemical markers such as TRIGLYCERIDES, Total CHOLESTEROL, HDL, LDL, Adiponectin, tumor necrosis factor and insulin would also be studied as they are associated with obesity of patient and insulin resistance. This study has been approved by ethical committee of the institution.
Methods: Study was performed as a randomized controlled trial and with parallel design. Physical examination and preliminary lab investigations patients of obesity induced DM will be selected. Serum glucose, cholesterol, triglycerides, HDL, LDL and HbA1c will be performed on semi auto analyzer according to the methodology & instructions given on literature accompanying commercially available kits of ERBATM.
Results: Study was done on 200 patients with type 2 diabetic patients to analyze the role of Leptin hormone in obesity induced type 2 DM. In the present study type-II diabetes patients were had significantly higher fasting blood glucose (P<0.001), glycosylated hemoglobin [HbA1c] (P <0.001), cholesterol (P=0.015) and high-density lipoprotein (P = 0.009), Low-density lipoprotein (<0.001) and non-significantly triglycerides (0.066) were observed. Further type-II diabetes patients were had significantly higher insulin (P<0.001), TNF- α (P <0.001), Leptin (P<0.001) and high adiponectin (P=0.001) were observed.
Conclusion: Although Type 2 diabetes can be treated with oral hypoglycemic drugs for long time but ultimately they require insulin to control their diabetes which has its side effects & available in injectable form only which is very cumbersome for the patient. Therefore it is necessary to look for other alternative therapy which has lesser side effects. Leptin together with other molecules that are secreted from adipose tissue does affect the insulin sensitivity & is accepted to play a major role in pathogenesis of obesity related diabetes.
Keywords: Diabetes, Obesity, Glucose, Leptin.
References
1. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014; 7: 587-591. doi:10.2147/DMSO.S67400.
2. Awasthi A, Parween N, Singh VK, Anwar A, Prasad B, Kumar J. Diabetes: Symptoms, Cause and Potential Natural Therapeutic Methods. Adv. in Diabetes and Metabolism. 2016; 4: 10-23. doi: 10.13189/adm.2016.040102.
3. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A and Zukel WJ. HDL cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation. 1977; 55: 767-772
4. Christian W, Funahashi T, Sachiyo T, Kikuko H, Yuji M, richard EP, and Antonio PT. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. The J of Clinical Endo & Metabol. 2001, 86 (5): 1930-35.
5. Fruhbeck, G, Gomez-Ambrosi, J, Muruzabal FJ, Burrell MA. Am. J. Physiol. Endocrinol. Metab. 2001, 280: E827–E847.
6. Hanson K, Pratley RE. Interleukin-6 is associated with insulin resistance independently of obesity (abstract). Diabetes. 2000; 49: A297.
7. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002; 40(1):78-89.
8. Johannes PB. Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab. 2002; 16(4):639-651.
9. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease; new perspectives based on the Framingham study. Ann Intern Med. 1979; 90:85.
10. Khoo CM, Sairazi S, Taslim S, et al. Ethnicity Modifies the Relationships of Insulin Resistance, Inflammation, and Adiponectin With Obesity in a Multiethnic Asian Population. Diabetes Care. 2011; 34(5):1120-1126. doi:10.2337/dc10-2097.
11. Kumar PA, Pandey D, Pandit A. Obesity and Lipid Profile Study in Type 2 Diabetes Patients with Auditory and Reaction Time Deficits and Non-diabetic Control Subjects. Advances in Diabetes and Metabolism. 5(1): 1-5, 2017
12. Luigi B & Kalabalik J. Management of Type-2 Diabetes Mellitus in Adults: Focus on Individualizing Non-Insulin Therapies. Pharmacy and Therapeutics. 2012; 12: 687–696.
13. Lundberg C, Jungles SJ, Richard C. Mulligan. Direct delivery of leptin to the hypothalamus using recombinant adeno-associated virus vectors results in increased therapeutic efficacy.Nature Biotechnology. 2001; 19, 169 - 172
14. Masur K, Thevenod F, Zanker KS:Diabetes and cancer. Epidemiological Evidence and Molecular links. Front Diabetes. 2008; 19.
15. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22 (12):1145-1158.
16. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Andrew SL, Panteghini M, Welch M, Eckfeldt JH. Recommendations for Improving Serum Creatinine Measurement: A report from laboratory working group of the National kidney disease education program. Clinical Chemistry. 2006; 52 (1): 5 – 18.
17. Nauck M, Warnick GR, Rifai N. Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation. Clinical Chemistry, 2002; 48 (2): 236-254.
18. Nedvídková J, Smitka K, Kopský V, Hainer V. Adiponectin, an adipocyte-derived protein. Physiol Res. 2005; 54 (2): 133–40.
19. Noureddine H, Nakhoul, N, Galal A, Soubra L & Saleh M. Level of A1C control and its predictors among Lebanese type 2 diabetic patients. Therapeutic Adv in Endo and Metabol. 2014; 5(3), 43–52.
20. Paz-Filho G, Mastronardi C, Wong M-L, Licinio J. Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J of Endo and Metabol. 2012; 16:S549-S555. doi:10.4103/2230-8210.105571.
21. Rajneesh Prajapat, Ijen Bhattacharya, Anupam Jakhalia. Combined Effect of Vitamin C and E Dose on Type 2 Diabetes Patients. Advances in Diabetes and Metabolism. 5: 21 - 25. doi: 10.13189/adm.2017.050201.
22. Renju VC, Santha K, Sethupathy S, Koshy M, Marichamy G & Kumaran SN. Serum Adiponectin and Fasting Insulin Levels in Patients with Type2 Diabetics. J. Pharm. Sci. & Res. 2012; 4(7): 1844 – 1847
23. Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003; 26 (5):1380-4.
24. World Health Organization, Diabetes mellitus, Technical Report Series 727, WHO, Geneva. 1985.
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.220
